7-Chloro-1,2,3,4-tetrahydro-1,8-naphthyridine, 95.0%, 250mg

1,3,5-Tri-O-benzoyl-alpha-D-ribofuranose>97.0%(HPLC)5g

N-Benzyl-2-chloro-N-ethylacetamide, 95+%, 5g

2-Methoxypyrimidine-5-boronic acid, 99.00%, 5g

Screw closures Polypropylene, GL 25, 12 Piece(s)

2-Thiophenecarboxamide, N-[2-(3,4-dihydro-3-oxo-2-quinoxalinyl)-4-(1-methylethyl)phenyl]-, 98%, 100mg

Bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate, 95%, 500g

7-TRIFLUOROMETHYLIMIDAZO[1,2-A]PYRIMIDINE, 97.0%, 5g

METHYL 5-AZASPIRO[2.4]HEPTANE-7-CARBOXYLATE HYDROCHLORIDE, 95%, 250mg

GC capillary column ROTI®Cap-5 MS, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

1,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

Lithioncarmine (powder)1g

Ethyl 3-hydroxy-2-methylbenzoate, 97%, 250mg